These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 29145795)
1. Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders. Zimmerman SM; Long ME; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ Vet Pathol; 2018 Mar; 55(2):258-267. PubMed ID: 29145795 [TBL] [Abstract][Full Text] [Related]
2. The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection. Zimmerman SM; Michel F; Hogan RJ; Lafontaine ER PLoS One; 2015; 10(5):e0126437. PubMed ID: 25993100 [TBL] [Abstract][Full Text] [Related]
3. Use of the common marmoset to study Burkholderia mallei infection. Jelesijevic T; Zimmerman SM; Harvey SB; Mead DG; Shaffer TL; Estes DM; Michel F; Quinn FD; Hogan RJ; Lafontaine ER PLoS One; 2015; 10(4):e0124181. PubMed ID: 25860021 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice. Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620 [TBL] [Abstract][Full Text] [Related]
6. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis. Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423 [TBL] [Abstract][Full Text] [Related]
8. Pathological and Immunohistochemical Analyses of Naturally Occurring Equine Glanders Using an Anti-BpaB Antibody. Erdemsurakh O; Purevdorj B; Ochirbat K; Adilbish A; Vanaabaatar B; Aoshima K; Kobayashi A; Kimura T Vet Pathol; 2020 Nov; 57(6):807-811. PubMed ID: 32885748 [TBL] [Abstract][Full Text] [Related]
9. The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of Dyke JS; Huertas-Diaz MC; Michel F; Holladay NE; Hogan RJ; He B; Lafontaine ER Virulence; 2020 Dec; 11(1):1024-1040. PubMed ID: 32799724 [TBL] [Abstract][Full Text] [Related]
10. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis. Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501 [TBL] [Abstract][Full Text] [Related]
11. A disruption of ctpA encoding carboxy-terminal protease attenuates Burkholderia mallei and induces partial protection in CD1 mice. Bandara AB; DeShazer D; Inzana TJ; Sriranganathan N; Schurig GG; Boyle SM Microb Pathog; 2008 Sep; 45(3):207-16. PubMed ID: 18614331 [TBL] [Abstract][Full Text] [Related]
12. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Galyov EE; Brett PJ; DeShazer D Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691 [TBL] [Abstract][Full Text] [Related]
14. Glanders: off to the races with Burkholderia mallei. Whitlock GC; Estes DM; Torres AG FEMS Microbiol Lett; 2007 Dec; 277(2):115-22. PubMed ID: 18031330 [TBL] [Abstract][Full Text] [Related]
15. Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders. Hatcher CL; Mott TM; Muruato LA; Sbrana E; Torres AG Infect Immun; 2016 Aug; 84(8):2345-54. PubMed ID: 27271739 [TBL] [Abstract][Full Text] [Related]
16. Development of Burkholderia mallei and pseudomallei vaccines. Silva EB; Dow SW Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691 [TBL] [Abstract][Full Text] [Related]
17. Type VI secretion is a major virulence determinant in Burkholderia mallei. Schell MA; Ulrich RL; Ribot WJ; Brueggemann EE; Hines HB; Chen D; Lipscomb L; Kim HS; Mrázek J; Nierman WC; Deshazer D Mol Microbiol; 2007 Jun; 64(6):1466-85. PubMed ID: 17555434 [TBL] [Abstract][Full Text] [Related]
18. Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice. Amemiya K; Meyers JL; Deshazer D; Riggins RN; Halasohoris S; England M; Ribot W; Norris SL; Waag DM Diagn Microbiol Infect Dis; 2007 Oct; 59(2):137-47. PubMed ID: 17908615 [TBL] [Abstract][Full Text] [Related]
19. Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus). Nelson M; Salguero FJ; Dean RE; Ngugi SA; Smither SJ; Atkins TP; Lever MS Int J Exp Pathol; 2014 Dec; 95(6):378-91. PubMed ID: 25477002 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]